{
 "awd_id": "8860654",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "Immunoassays for Identification of Blood Residues on        Archeological Samples",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Ritchie B. Coryell",
 "awd_eff_date": "1989-01-01",
 "awd_exp_date": "1989-09-30",
 "tot_intn_awd_amt": 50000.0,
 "awd_amount": 50000.0,
 "awd_min_amd_letter_date": "1988-12-07",
 "awd_max_amd_letter_date": "1988-12-07",
 "awd_abstract_narration": "The recent discovery that traces of blood can be identified on                  ancient stone implements has opened a new area of archaeological                inquiry.  It has allowed archaeologists to determine the function               of specific kinds of stone tools (a subject of continuing debate)               and in some instances to identify the actual species.  A number                 of analytic techniques have been tried but all have drawbacks.                  In preliminary work, Dr. Anderson has demonstrated the potential                of nitrocellulose-binding enzyme immunoassay (EIA).  He will now                generate three groups of species specific antibodies and apply                  them as a test case to archaeological materials from two sites.                 If successful, this will permit the development of additional                   antibodies and their application, in a routine manner, to                       archaeological materials.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Thomas",
   "pi_last_name": "Anderson",
   "pi_mid_init": "R",
   "pi_sufx_name": "",
   "pi_full_name": "Thomas R Anderson",
   "pi_email_addr": "",
   "nsf_id": "000243942",
   "pi_start_date": "1989-01-01",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "Berkeley Antibody Company",
  "inst_street_address": "4131 Lakeside Drive, Suite B",
  "inst_street_address_2": "",
  "inst_city_name": "Richmond",
  "inst_state_code": "CA",
  "inst_state_name": "California",
  "inst_phone_num": "5102224940",
  "inst_zip_code": "948061942",
  "inst_country_name": "United States",
  "cong_dist_code": "08",
  "st_cong_dist_code": "CA08",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "DATA NOT AVAILABLE",
  "perf_str_addr": "",
  "perf_city_name": "",
  "perf_st_code": "",
  "perf_st_name": "RI REQUIRED",
  "perf_zip_code": "",
  "perf_ctry_code": "",
  "perf_cong_dist": "",
  "perf_st_cong_dist": "",
  "perf_ctry_name": "",
  "perf_ctry_flag": "0"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "1391",
   "pgm_ref_txt": "ARCHAEOLOGY"
  },
  {
   "pgm_ref_code": "5371",
   "pgm_ref_txt": "SMALL BUSINESS PHASE I"
  }
 ],
 "app_fund": [
  {
   "app_code": "",
   "app_name": "",
   "app_symb_id": "",
   "fund_code": "",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 1989,
   "fund_oblg_amt": 50000.0
  }
 ],
 "por": null
}